REPLIGEN CORP acquires Engineered Molding Technology LLC (EMT)

REPLIGEN CORP acquired Engineered Molding Technology LLC (EMT) for NULL (part of $175.0M combined cash used for EMT, NMS and ARTeSYN in 2020), a transaction completed in July 2020, structured as all cash.

Engineered Molding Technology LLC (EMT) operates in Fluid Management / Filtration, is based in Whippany / New Jersey, USA. Acquisition of Engineered Molding Technology LLC, a manufacturer of single-use silicone assemblies and components used in the manufacture of biologic drugs. EMT expands Repligen's ProConnex flow-path line and streamlines its ATF supply chain. Effective July 11, 2021, EMT was absorbed into Repligen via short-form merger.

Hunt said 'the acquisition of EMT expands our line of single-use ProConnex flow paths, streamlines our supply chain for ATF, and gives us more flexibility as we scale.'

Vertical integration of single-use silicone flow-path supply. Supply-chain integration for ATF and ProConnex. Repligen Fluid Management / Filtration (absorbed via short-form merger Jul 11, 2021)